Delivery Order SPE2DR25D3012-SPE2DR26F4E0Y
Award Date 12/29/25
Potential Completion Date 12/30/25
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order contract award from the Defense Logistics Agency (DLA) on December 18, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls. This firm fixed-price delivery order, valued at $2,387.94, is set to be completed by December 19, 2025, and will be fulfilled at the contractor's Conshohocken facility. The contract represents a non-set-aside, competitively awarded...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 19, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. This non-set-aside, competitively awarded contract has a ceiling value of $3,815.69 and is structured as a firm fixed price delivery order with an ultimate completion date of December 22, 2025. The award...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 8, 2025, for Humira Pen 40 mg/0.8 mL with a ceiling value of $5,569.20. This competitively awarded, firm fixed-price delivery order is not set aside for any specific business category and has an ultimate completion date of September 9, 2025. The award represents a pharmaceutical supply requirement for military...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 22, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mls, a biologic medication used to treat inflammatory conditions. This is a firm fixed-price delivery order with a ceiling value of $4,531.80 and an ultimate completion date of May 23, 2025. The contract is non-competitive with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.96 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used to treat autoimmune conditions. This competitive award, issued on December 29, 2025, with an ultimate completion date of December 30, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $12,704.63 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. The contract is a firm fixed price delivery order with no set-aside designation, reflecting an open and competitive award process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a brand-name pharmaceutical product used to treat autoimmune conditions. This firm fixed-price delivery order carries a ceiling value of $21,762.78 and is scheduled for completion by December 3, 2025. The award represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in treating autoimmune conditions. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,156.39 and is scheduled for completion by September 5, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,461.43 on September 22, 2025, for the supply of Humira Pen 40mg/4mL (2 single-dose pens). This firm fixed price, competitively awarded contract contains no set-aside designation and is set for completion by September 23, 2025. The award is funded through the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceutical products...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $20,325.24 by the Defense Logistics Agency on November 17, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by November 18, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999...